Related Experiment Video

Updated: May 22, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Treatment of COPD: moving beyond the lungs

M Gabriella Matera1, Luigino Calzetta, Barbara Rinaldi

  • 1Department of Experimental Medicine, Second University of Naples, Naples, Italy. mariagabriella.matera@unina2.it

Current Opinion in Pharmacology
|May 4, 2012
PubMed

Insights

Treating cardiovascular diseases in COPD patients may improve lung health and survival. Current research suggests statins and other cardiovascular drugs could reduce hospitalizations and mortality in COPD patients.

Area of Science:

  • Pulmonary Medicine
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Chronic Obstructive Pulmonary Disease (COPD) frequently co-occurs with cardiovascular diseases (CVD).
  • The impact of treating these comorbid CVDs on COPD progression and patient outcomes remains unclear due to limited definitive data.
  • Existing observational studies indicate potential benefits of certain cardiovascular medications in COPD patients.

Purpose of the Study:

  • To investigate whether the treatment of comorbid cardiovascular diseases influences the course of Chronic Obstructive Pulmonary Disease.
  • To assess the potential of cardiovascular medications to reduce morbidity and mortality rates in patients with COPD.

Main Methods:

  • Review of observational studies examining COPD patients treated with specific cardiovascular medications.
  • Analysis of pharmacological mechanisms through basic and translational research.
  • Monitoring of early-stage clinical trial results.

Main Results:

  • Observational data suggest improved survival and reduced hospitalizations for COPD exacerbations in patients using statins, angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin II type 1 receptor blockers (ARBs), and beta-blockers (β-adrenoceptor blockers).
  • Basic and translational research is elucidating potential pharmacological mechanisms underlying these observed effects.
  • Early clinical trials are yielding promising, albeit preliminary, results.

Conclusions:

  • Treatment of cardiovascular comorbidities in COPD patients may positively impact lung disease course and overall survival.
  • Specific cardiovascular drugs like statins, ACE inhibitors, ARBs, and beta-blockers show potential for improving outcomes in COPD.
  • Further clinical research is warranted to confirm these findings and establish treatment guidelines.

More Related Videos

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment